Insights into Fracture Risk with Tenofovir and Entecavir: Evidence from Pharmacovigilance Data

IF 26.8 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Wukun Ge, Zhen Wei, Haiyan Xie
{"title":"Insights into Fracture Risk with Tenofovir and Entecavir: Evidence from Pharmacovigilance Data","authors":"Wukun Ge, Zhen Wei, Haiyan Xie","doi":"10.1016/j.jhep.2024.10.014","DOIUrl":null,"url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Funding information</h2>The study was supported by Quzhou City Science and Technology Research Project in 2023 (Grant No. 2023k193)</section></section><section><section><h2>Authors' contributions:</h2>Wukun Ge: Formal analysis, Investigation, Writing - original draft, Writing - review &amp; editing; Zhen Wei: Investigation, Writing - review &amp; editing; Haiyan Xie: Conceptualization, Methodology, Project administration, Resources, Supervision, Writing - review &amp; editing.</section></section><section><section><h2>Data Availability Statement</h2>This data can be accessed through the FDA's FAERS Public Dashboard at <span><span>https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span>.</section></section><section><section><h2>Declaration of Competing Interest</h2>The authors disclose no conflicts.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"32 1","pages":""},"PeriodicalIF":26.8000,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhep.2024.10.014","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Section snippets

Funding information

The study was supported by Quzhou City Science and Technology Research Project in 2023 (Grant No. 2023k193)

Authors' contributions:

Wukun Ge: Formal analysis, Investigation, Writing - original draft, Writing - review & editing; Zhen Wei: Investigation, Writing - review & editing; Haiyan Xie: Conceptualization, Methodology, Project administration, Resources, Supervision, Writing - review & editing.

Data Availability Statement

This data can be accessed through the FDA's FAERS Public Dashboard at https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html.

Declaration of Competing Interest

The authors disclose no conflicts.
透视替诺福韦和恩替卡韦的骨折风险:来自药物警戒数据的证据
章节片段资助信息本研究得到衢州市2023年科技攻关项目(批准号:2023k193)的资助:谢海燕:构思、方法学、项目管理、资源、指导、写作-审阅和编辑。数据可用性声明该数据可通过FDA的FAERS公共仪表板访问:https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html.Declaration of Competing Interest作者未披露任何冲突。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Hepatology
Journal of Hepatology 医学-胃肠肝病学
CiteScore
46.10
自引率
4.30%
发文量
2325
审稿时长
30 days
期刊介绍: The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信